COMMUNIQUÉS West-GlobeNewswire

Kestrel Therapeutics Receives FDA Fast Track Designation for KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in the treatment of KRAS-Mutant Advanced Solid Tumors
15/09/2026
WATERTOWN, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical-stage biotechnology company developing next-generation small-molecule inhibitors targeting mutant [...]
Addgene Launches Transfection-Ready DNA Service to Accelerate Academic and Industry Research
15/09/2026
Sourced from Addgene’s trusted repository, thousands of plasmids are now available to researchers as high-purity, NGS sequence-verified DNA WATERTOWN, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Addgene , a purpose-driven [...]
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
15/09/2026
Landmark independent study reports significantly improved task performance and satisfaction and lower pain compared with wheelchair use ReWalk users with chronic spinal cord injury were able to perform everyday kitchen [...]
NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum
15/09/2026
SANTA ANA, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
15/09/2026
CHICAGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer, today [...]
Dimenso Raises $650,000 to Bring Physical AI and Smart Glasses to Life Sciences Laboratories
15/09/2026
Boston-based company backed by Draper B1 and Next Tier Ventures is building AI infrastructure to capture, structure, and understand scientific work as it happens Dimenso has raised $650,000 from Draper B1 and Next Tier [...]
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
15/09/2026
Payment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 million Company remains eligible for up to approximately $10 million in additional proceeds [...]
PolyPid Announces Participation in Upcoming Fall Investor Conferences
15/09/2026
PETACH TIKVA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Sienna Announces September Dividend
15/09/2026
MARKHAM, Ontario, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing
15/09/2026
ERNA-201 demonstrated encouraging disease-modifying activity in the industry-standard collagen-induced arthritis model, providing meaningful proof-of-concept for Ernexa's engineered synthetic iMSC platform beyond [...]
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
15/09/2026
LAS VEGAS, NV, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related [...]
Tria Federal Achieves CMMC Level 2 Certification, Affirming Its Ability to Protect Sensitive Federal Data
15/09/2026
Rigorous, independent audit confirms Tria's security controls meet the Department of War’s standard ARLINGTON, Va., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced that it has achieved Cybersecurity [...]
MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31
15/09/2026
Chaired by Mo Qatanani, PhD, Clinical & Scientific Advisory Board brings deep expertise in obesity, cardiometabolic disease and drug development Board will guide MitoRx's development strategy for lead asset MTRX31 [...]
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
15/09/2026
-- Leading multi-site OB/GYN health practice to implement FemVue ® for fertility diagnostic evaluation and FemaSeed for first-line treatment across all four locations -- ATLANTA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- [...]
New Imprivata Research Finds 72% of Healthcare Organizations Have AI Tools or Agents Deployed Without Formal IT Approval
15/09/2026
Survey of U.S. healthcare leaders reveals that AI adoption is accelerating, but unapproved deployments and fragmented identity security strategies create governance challenges WALTHAM, Mass., Sept. 15, 2026 (GLOBE [...]
KORTUC Achieves Target Enrollment in Registrational Breast Cancer Trial as Three Global Clinical Programs Advance
15/09/2026
The 184-patient milestone moves KORTUC's lead program toward readout, alongside a cervical cancer study with UC San Diego and newly authorized K-BOOST rectal cancer trial in France PALO ALTO, Calif., Sept. 15, 2026 ( [...]
SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit
15/09/2026
HydraScalp with Keravive study highlights improvements in scalp hydration and overall scalp quality following a single treatment Hydrafacial study shows improvements in skin hydration and overall skin quality following [...]
Clene Announces $4 Million Registered Direct Offering
15/09/2026
Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders $4 million registered direct [...]
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
15/09/2026
New program targets peripheral nerve regeneration and restoration of nerve function SCOTTSDALE, Ariz., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Applied Biologics today announced the launch of APPB-429, a new gene therapy [...]

Pages